Cytochrome P450 3A4, 3A5, and 2C8 expression in breast, prostate, lung, endometrial, and ovarian tumors: relevance for resistance to taxanes-Reference-Cited by-同舟云学术

Cytochrome P450 3A4, 3A5, and 2C8 expression in breast, prostate, lung, endometrial, and ovarian tumors: relevance for resistance to taxanes

Published:2019-07-15 Issue:3 Volume:84 Page:487-499
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

van Eijk Maarten^ORCID,Boosman René J.,Schinkel Alfred H.,Huitema Alwin D. R.,Beijnen Jos H.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-019-03905-3.pdf

Reference125 articles.

1. World Health Organization International Agency for Research on Cancer (IACR) (2018) GLOBOCAN 2018: IARC Global Cancer Observatory. http://gco.iarc.fr/today/home . Accessed 31 May 2019

2. Montero A, Fossella F, Hortobagyi G, Valero V (2005) Docetaxel for treatment of solid tumours: a systematic review of clinical data. Lancet Oncol 6:229–239. https://doi.org/10.1016/S1470-2045(05)70094-2

3. Crown J, O’Leary M (2000) The taxanes: an update. Lancet 355:1176–1178. https://doi.org/10.1016/S0140-6736(00)02074-2

4. Akram T, Maseelall P, Fanning J (2005) Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer. Am J Obstet Gynecol 192:1365–1367. https://doi.org/10.1016/j.ajog.2004.12.032

5. Tannock IF, de Wit R, Berry WR et al (2004) Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 351:1502–1512. https://doi.org/10.1056/NEJMoa040720

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, characterization, antimicrobial screening and in-silico studies of thiadiazole derivatives;Journal of Molecular Structure;2024-11

2. Structural Characterization of Heat Shock Protein 90β and Molecular Interactions with Geldanamycin and Ritonavir: A Computational Study;International Journal of Molecular Sciences;2024-08-12

3. Key genes and molecular mechanisms related to Paclitaxel Resistance;Cancer Cell International;2024-07-13

4. Identification of ribosomal protein S21 as a potential prognostic and immunotherapy biomarker for hepatocellular carcinoma;Asian Journal of Surgery;2024-07

5. Deciphering the Molecular Mechanisms behind Drug Resistance in Ovarian Cancer to Unlock Efficient Treatment Options;Cells;2024-05-04